Medication recommendations to physicians by pharmacists for seniors: expected clinical impact in relation to implementation and expected time frame to effect

Aims and objectives To describe recommendations made by pharmacists in a trial that had found no improvements in selected clinical outcomes (the Seniors Medication Assessment Research Trial, SMART) in terms of expected impact on clinical outcomes and whether they had been implemented by the end of the 5‐month period of follow‐up.

[1]  Wanzhu Tu,et al.  Pharmacist Intervention to Improve Medication Adherence in Heart Failure , 2007, Annals of Internal Medicine.

[2]  P. Kaboli,et al.  Development and Reliability Testing of the Clinical Pharmacist Recommendation Taxonomy , 2007, Pharmacotherapy.

[3]  R. Holland,et al.  Home-based medication review in a high risk elderly population in primary care--the POLYMED randomised controlled trial. , 2007, Age and ageing.

[4]  J. Nachega,et al.  Effect of a Collaborative Approach on the Quality of Prescribing for Geriatric Inpatients: A Randomized, Controlled Trial , 2007, Journal of the American Geriatrics Society.

[5]  R. Abbott,et al.  Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension , 1998, Journal of General Internal Medicine.

[6]  Jer-shiarn. Lee,et al.  Outcomes of recommendations by hospice pharmacists. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[7]  D. Pham.  Evaluating the Impact of Clinical Interventions by PharmD Students on Internal Medicine Clerkships: The Results of a 3 Year Study , 2006, The Annals of pharmacotherapy.

[8]  J. Chan,et al.  Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial , 2006, BMJ : British Medical Journal.

[9]  J. Fornos,et al.  A Pharmacotherapy Follow-Up Program in Patients with Type-2 Diabetes in Community Pharmacies in Spain , 2006, Pharmacy World and Science.

[10]  R. Abbott,et al.  The Physician and Pharmacist Team: An Effective Approach to Cholesterol Reduction , 1997, Journal of General Internal Medicine.

[11]  C. Paulos,et al.  Impact of a Pharmaceutical Care Program in a Community Pharmacy on Patients with Dyslipidemia , 2005, The Annals of pharmacotherapy.

[12]  R. Hayward,et al.  Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. , 2005, The American journal of managed care.

[13]  P. Odegard,et al.  Caring for Poorly Controlled Diabetes Mellitus: A Randomized Pharmacist Intervention , 2005, The Annals of pharmacotherapy.

[14]  V. Sidel,et al.  Controlled study of the impact of educational home visits by pharmacists to high-risk older patients , 1990, Journal of Community Health.

[15]  D. Purdie,et al.  Medication reviews in the community: results of a randomized, controlled effectiveness trial. , 2004, British journal of clinical pharmacology.

[16]  A. Egberts,et al.  Evaluation of the clinical value of pharmacists' modifications of prescription errors. , 2004, British journal of clinical pharmacology.

[17]  J. McElnay,et al.  Community pharmacy based provision of pharmaceutical care to older patients , 2003, Pharmacy World and Science.

[18]  M. Roberts,et al.  Development of a quality use of medicines coding system to rate clinical pharmacists' medication review recommendations , 2004, Pharmacy World and Science.

[19]  R. Goeree,et al.  A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[20]  R. Kassam,et al.  Reliability of a modified medication appropriateness index in community pharmacies. , 2003, The Annals of pharmacotherapy.

[21]  E. Vivian.  Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension Clinic , 2002, Pharmacotherapy.

[22]  J. Cabrita,et al.  Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. , 2002, Journal of the American Pharmaceutical Association.

[23]  K. Knapp,et al.  Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[24]  K. Teo,et al.  A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). , 2002, Archives of internal medicine.

[25]  P. Campion,et al.  Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care , 2002, Palliative medicine.

[26]  C. Woodward,et al.  Recruiting family physicians and patients for a clinical trial: lessons learned. , 2002, Family practice.

[27]  P. Montgomery,et al.  Impact of a pharmaceutical care model for non‐institutionalised elderly: results of a randomised, controlled trial , 2001 .

[28]  R. Kassam,et al.  Pharmaceutical care research and education project: patient outcomes. , 2001, Journal of the American Pharmaceutical Association.

[29]  M. Rioux,et al.  Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[30]  J. Krska,et al.  Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. , 2001, Age and ageing.

[31]  C. Bernsten,et al.  Improving the Well-Being of Elderly Patients via Community Pharmacy-Based Provision of Pharmaceutical Care , 2001, Drugs & aging.

[32]  T. Bailey,et al.  A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. , 1999, Archives of internal medicine.

[33]  H. Cohen,et al.  A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. , 1996, The American journal of medicine.

[34]  L. Jaber,et al.  Evaluation of a Pharmaceutical Care Model on Diabetes Management , 1996, The Annals of pharmacotherapy.

[35]  G. Guyatt,et al.  Users' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations , 1995 .

[36]  R J Cook,et al.  Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. , 1995, JAMA.

[37]  J. Jameson,et al.  The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. , 1995, The Journal of family practice.

[38]  H. Cohen,et al.  A method for assessing drug therapy appropriateness. , 1992, Journal of clinical epidemiology.

[39]  R. Tallis,et al.  Inappropriate medication is a major cause of adverse drug reactions in elderly patients. , 1992, Age and ageing.

[40]  S. Mcphee,et al.  The Impact of Clinical Pharmacists' Consultations on Physicians' Geriatric Drug Prescribing: A Randomized Controlled Trial , 1992, Medical care.

[41]  L. Bero,et al.  Characterization of Geriatric Drug-Related Hospital Readmissions , 1991, Medical care.

[42]  N. Col,et al.  The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. , 1990, Archives of internal medicine.

[43]  R. Stewart.  Polypharmacy in the Elderly: A Fait Accompli? , 1990, DICP : the annals of pharmacotherapy.

[44]  C. Hepler,et al.  Opportunities and responsibilities in pharmaceutical care. , 1990, American journal of hospital pharmacy.

[45]  P. Gal,et al.  Effect of pharmacist intervention on control of resistant hypertension. , 1986, American journal of hospital pharmacy.

[46]  J. Mckenney,et al.  Drug-related hospital admissions. , 1976, American journal of hospital pharmacy.